AccurECG is AccurKardia's FDA-cleared Class II software as a medical device (SaMD) platform for fully automated, near real-time ECG interpretation. AccurECG provides beat-by-beat analysis, ventricular ...
TORONTO, ONTARIO / ACCESSWIRE / CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") a global medical provider of electrocardiogram ("ECG") acquisition and management ...
NEW YORK--(BUSINESS WIRE)--AccurKardia, an innovator in ECG-based diagnostics technology, has announced the initiation of a multicenter clinical pilot of AK+ Guard TM, an FDA Breakthrough Device ...
Boston, MA—October 22, 2025: ECG Management Consultants, a leading consulting firm to health systems and payers, today announced the addition of STAMP, a SaaS-based platform that enables payers to ...
NEW YORK--(BUSINESS WIRE)--AccurKardia, an ECG-led diagnostics software company, today announced a multi-year agreement with Lucem Health, a leading provider of clinical AI solutions. The partnership ...
Electrocardiogram software analytics company AccurKardia is joining the Innovators’ Network at the American Heart Association Center for Health and Technology Innovation. The Innovator’s Network is a ...
GEMS(TM) Rhythm AI Clearance will Address Event, Holter and Long-Term Continuous ECG Monitoring Needs for Remote Patient Monitoring in Canada The GEMS Rhythm arrhythmia and morphology abnormality AI ...
Austin, Texas, United States, January 5th, 2026, FinanceWire HeartBeam (NASDAQ: BEAT), a medical technology company focused ...
Apple’s latest smartwatch can now detect signs of a deadly heart condition – potentially saving lives across the UK. But Dr Helen Tyrer, a senior clinical research fellow at Imperial College London, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback